P

PhaseV

SaaS platform for adaptive clinical trials

Medical Director

Biology & BiotechConfirmed live in the last 24 hours
Full-timeTel Aviv-Yafo, IsraelNo salary listed

About the Job

Requirements

  • An M.D. degree is required.
  • Fluent in English.
  • Ability to thrive in a fast-paced, interdisciplinary startup environment.
  • Curiosity and willingness to engage with advanced biostatistics and causal machine learning; technical expertise is not required.

Responsibilities

  • Provide clinical oversight and interpretation for PhaseV's causal machine-learning-based models across all product modules.
  • Ensure clinical relevance and accuracy in platform outputs and client deliverables.
  • Serve as a clinical expert in client-facing discussions, translating data science outputs into actionable medical insights.
  • Guide internal data science, engineering, and product teams on clinical concepts relevant to ongoing projects.
  • Partner with the business development team to communicate PhaseV's clinical value proposition to pharma, biotech, and CRO partners.
  • Participate in client meetings, partnership discussions, and proposal development as a clinical subject matter expert.
  • Develop and refine presentation content for business development meetings, pitches, and scientific discussions.
  • Partner with product and data science teams to inform new platform capabilities.
  • Provide clinical feasibility input during early-stage product ideation and design.
  • Help define clinically meaningful use cases, endpoints, and success criteria for new offerings.

Desired Qualifications

  • Experience supporting business development efforts.
  • Experience in pharmaceutical, biotech, or CRO environments.
  • Experience in health technology, AI in healthcare, or related fields.
  • A track record of thought leadership, such as publications, conference presentations, or industry writing.
  • Prior exposure to adaptive trial design, Bayesian methods, or AI/ML in clinical settings.
  • Working knowledge of clinical trial methodology and regulatory frameworks, including FDA, EMA, and GCP.
  • A second advanced degree, such as a Ph.D. or MBA, is a differentiator but is not required.

About the Company

PhaseV

SaaS platform for adaptive clinical trials

PhaseVTrials provides a subscription-based software platform that helps pharmaceutical companies, biotech firms, and research teams design, manage, and run adaptive clinical trials. It combines reinforcement learning and causal machine learning to optimize decisions at any stage of a trial, with an intuitive user interface and flexible software architecture that adapts to different clinical needs. Users access the platform via SaaS and can also receive consulting help to fine-tune trial designs and execution strategies. Compared with others, PhaseVTrials offers a distinct mix of advanced data-driven algorithms and a user-friendly tool that delivers real-time insights, aiming to shorten trial timelines and reduce costs. The company’s goal is to accelerate drug development by enabling efficient, data-informed adaptive trials.

Company size
51-200
Company stage
Series A
Total funding
$65M
Headquarters
Tel Aviv-Yafo, Israel
Founded
2023

Recently Posted Jobs

Explore more opportunities at PhaseV

See more jobs